Literature DB >> 10840938

The expression of products of oncogens c-erbB2 and EGFR and proliferating antigens Ki67 and PCNA in primary invasive ductal cancer of female breast.

A Jeziorski1, J Z Blonski, H Niewiadomska.   

Abstract

The aim of the study was to examine the consecutive series of primary ductal invasive tumours and find out: a) the expression of some biological cellular parameters as proliferating antigens Ki67 and PCNA and products of gene EGFR, erbB2; b) correlation between the levels of expression of those factors and classical prognostic factors, such as diameter of tumour, status of axillary lymph nodes, status of steroids receptors, the degree of histological differentiation. We found that: 1. The presence of the expression of oncoproteins c-erbB2 and EGFR, high index IP PCNA, Ki67 and low levels of steroids receptors correlates with high histological malignancy (Bloom III0); 2. The lack of expression of oncoproteins c-erbB2, EGFR and low index IP PCNA, Ki67 correlates with high levels of steroids receptors; 3. The estimation of high levels of index IP PCNA, IP Ki67 can be helpful for separate tumours of high proliferating activity; 4. The expression of oncoprotein c-erbB2 and EGFR does not correlate with the diameter of tumour as well as with the involvement of axillary lymph nodes. It seems that the estimation of proliferating antigens together with the expression of oncoproteins might have greater prognostic value than the estimation of one of these factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10840938

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  6 in total

1.  Construction of the antisense eukaryotic vector for proliferating cell nuclear antigen gene and its expression in bladder cancer EJ cell line.

Authors:  Qiangsong Tong; Fuqing Zeng; Yipeng Qi; Zhaohui Zhu; Gongcheng Lu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

2.  Expression of cell cycle proteins in male breast carcinoma.

Authors:  Rani Kanthan; Isabella Fried; Theresa Rueckl; Jenna-Lynn Senger; Selliah Chandra Kanthan
Journal:  World J Surg Oncol       Date:  2010-02-12       Impact factor: 2.754

3.  Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumors.

Authors:  Matthew E Hardee; Rose J Eapen; Zahid N Rabbani; Matthew R Dreher; Jeffrey Marks; Kimberly L Blackwell; Mark W Dewhirst
Journal:  Cancer Chemother Pharmacol       Date:  2008-03-26       Impact factor: 3.333

4.  gef gene expression in MCF-7 breast cancer cells is associated with a better prognosis and induction of apoptosis by p53-mediated signaling pathway.

Authors:  Houria Boulaiz; Pablo J Alvarez; Jose Prados; Juan Marchal; Consolación Melguizo; Esmeralda Carrillo; Macarena Peran; Fernando Rodríguez; Alberto Ramírez; Raúl Ortíz; Antonia Aránega
Journal:  Int J Mol Sci       Date:  2011-10-31       Impact factor: 5.923

5.  Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?

Authors:  A Elzagheid; T Kuopio; S Pyrhönen; Y Collan
Journal:  Diagn Pathol       Date:  2006-11-08       Impact factor: 2.644

6.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.